$EOLS 3 SEC Filings

Filed On	Filing
09 Oct 2025	Form 3: Mitchell Tatjana, Chief Financial Officer No securities owned
03 Jul 2024	Form 3: White Albert G Iii, Director No securities owned
23 Aug 2023	Form 3: Yamagishi-Dressler Tomoko, Chief Marketing Officer No securities owned
06 Sep 2022	Form 3: Beaver Sandra, Chief Financial Officer No securities owned
07 Jan 2022	Form 3: Stewart Brady, Director No securities owned
01 Mar 2021	Form 3: Muilenburg Crystal, Chief Marketing Officer Holds 96,105 shares of Common Stock
01 Mar 2021	Form 3: Medytox Inc., 10% owner Holds 6,762,652 shares of Common Stock, $0.00001 par value per share
10 Jan 2020	Form 3: Alphaeon 1 Llc, 10% owner Holds 8,662,346 shares of Common Stock
17 Jul 2019	Form 3: Parschauer Karah Herdman, Director No securities owned
17 Jul 2019	Form 3: Farrell Peter C, Director No securities owned
20 Jun 2018	Form 3: Jafar Michael M., Chief Marketing Officer Holds 200 shares of Common Stock
31 May 2018	Form 3: Silvernail Lauren P, See Remarks No securities owned
08 May 2018	Form 3: Moatazedi David, Director No securities owned
12 Feb 2018	Form 3: Gill David N, Director No securities owned
07 Feb 2018	Form 3: Romine Kristine, Director
07 Feb 2018	Form 3: Malik Vikram, Director
07 Feb 2018	Form 3: Marmo J Christopher, Chief Operating Officer No securities owned
07 Feb 2018	Form 3: Alphaeon Corp, 10% owner Holds 16,527,000 shares of Common Stock
07 Feb 2018	Form 3: Avelar Rui, Chief Medical Officer Holds 100,224 shares of Common Stock
07 Feb 2018	Form 3: Hayman Robert, Director

Comments